INSM
Insmed Incorporated
Latest News for INSM
Insmed ($INSM) announced an update on their ongoing clinical study. Study Overview: Insmed’s ENCORE trial (NCT04677569) is a phase 3 study testing ......
Morgan Stanley analyst Maxwell Skor maintained a Hold rating on Insmed today and set a price target of $162.00. Skor covers the Healthcare sector, ......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Insmed (INSM – Research Report) and Sanara MedTech (......
Stifel Nicolaus analyst Adam Walsh initiated coverage with a Buy rating on Insmed today and set a price target of $212.00. According to TipRanks, W......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Insmed (INSM – Research Report) and Roche Holding AG......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Siemens Healthineers AG (SEMHF – Research Report) an......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Karyopharm Therapeutics (KPTI – Research Report), Es......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Establishment Labs Holdings (ESTA – Research Repor......
Insmed ( ($INSM) ) has shared an announcement. On January 9, 2026, Insmed reported strong preliminary unaudited 2025 financial results and pipeline......
UBS analyst Trung Huynh maintained a Buy rating on Insmed today and set a price target of $215.00. According to TipRanks, Huynh is a 5-star analyst......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 10 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INSM | $156.46 | +1.6% | 1.51M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |